Companies · Healthtech

Teladoc Health, Inc.

PURCHASE · Healthtech · refined from filed group “Other Health Care · https://www.teladochealth.com/

Diligence memoA one-page analyst read on Teladoc Health, Inc. — recommendation, valuation, rhythm, risks.
$1.1B
Total raised · real
8
Rounds
12.8×
Latest step-up
Top 1%
Sector rank · raised
Growth/Late
Latest stage · inferred · Wed Jul 01 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

Teladoc Health, Inc. has raised $1.1B over 8 rounds; too few niche peers to rank its valuation yet.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the healthtech sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Dormant
  • Last raise 6.0 yr ago; this sector typically re-raises about every 14 months.
  • Silent for over 3× the sector's normal cadence.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Healthtech

Teladoc Health, Inc. is one of 2138 Healthtech companies tracked from PURCHASE. By capital raised it ranks among the largest (ahead of 100% of sector peers), and among the largest by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

AI analyst read est. — model-extracted from this company's public description, not a verified fact. 30%

operates a technology-led product inferred from public copy

Grounded in: “You are a venture analyst

Get 24/7 access to doctors, mental health support and specialty care with virtual healthcare and telehealth solutions for individuals and organizations from Teladoc Health.

Get 24/7 access to doctors, mental health support and specialty care with virtual healthcare and telehealth solutions for individuals and organizations from Teladoc Health. Skip the trip and get same-day care for common conditions. Teladoc Health offers comprehensive care including talk therapy, diagnosis and medication support. BetterHelp will find your perfect match in a network of 30,000 therapists. Weight loss and healthy living tailored to you. A personalized way to manage and prevent diabetes. Lowering your blood pressure just got easier. Skin issues? Meal planning? Or need a second opinion? We've got you covered. Looking for convenient, high-quality primary care? Welcome. Comprehensive care for better employee health Integrated care solutions for commercial and government populations Enabling virtual care at scale from hospital to home Explore career opportunities and resources for providers. Meet our leadership team and explore their roles. Interested in joining our world-class team? View our openings. Teladoc Health connects patients and care providers for medical care, mental health, chronic condition management and more. Talk to a medical provider anytime, day or night.

healthtech
Find Teladoc Health online

Trades publicly as Teladoc Health.

As reported in public records reported — not modeled.

US
Jurisdiction
Rule 506(b)
Reg D exemption
172
Investors (latest)
2020-07-01
First sale
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$12.5B$25.0B$37.5B$50.0BSeries A · 2009-11-19 Raised $8.9M (real) Modeled valuation $201M (est)Series A2009Series A · 2010-12-21 Raised $4.0M (real) Modeled valuation $90M (est)Series A2010Series B · 2011-08-25 Raised $19M (real) Modeled valuation $461M (est)Series B2011Series B · 2013-08-28 Raised $15M (real) Modeled valuation $372M (est)Series B2013Series C · 2014-09-09 Raised $50M (real) Modeled valuation $1.3B (est)Series C2014Series C · 2016-07-01 Raised $80M (real) Modeled valuation $2.0B (est)Series C2016Series C · 2017-07-14 Raised $65M (real) Modeled valuation $1.7B (est)Series C2017Growth/Late · 2020-07-01 Raised $834M (real) Modeled valuation $22.1B (est)Growth/Late2020+$4.0M+$19M+$15M+$50M+$80M+$65M+$834MCumulative $1.1B

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Series A$8.9M · 2009
Series A extension$4.0M · 2010
Series B$18.6M · 2011
Series B extension$15.0M · 2013
Series C$50.3M · 2014
Series C extension$80.0M · 2016
Series C extension$65.0M · 2017
Growth/Late$834.0M · 2020no Series D+ on file

Stages are modeled from round size (public records carry no series label). No record for: Pre-Seed, Seed, Series D+ — the company may have raised it under a different exemption, merged it into an adjacent record, or skipped it. Sequence completeness: 57%.

Modeled valuation trajectory
$22.1B
Base estimate est.
$6.1B
Conservative case
$39.8B
Upside case
$8.3B
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Growth/Latea round over $400M). Valuation is modeled from stage benchmarks scaled by the healthtech sector profile. Directional, not a quoted figure.

Series A · modeled $200.9M · 2009-11-192009Series A · modeled $90.3M · 2010-12-21Series B · modeled $461.0M · 2011-08-25Series B · modeled $371.8M · 2013-08-28Series C · modeled $1.3B · 2014-09-09Series C · modeled $2.0B · 2016-07-01Series C · modeled $1.7B · 2017-07-14Growth/Late · modeled $22.1B · 2020-07-012020
Model inputs · modeled:benchmark-stage-stepup-v1
10%
Dilution assumption
Implied ownership sold in the financing.
85%
Survival probability
73% low · 91% high
1.21×/yr
Annual markup
1.32×/yr upside case
6.0 yr
Elapsed time used
6.0 yr actual, capped for stale marks
healthtech
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
18 mo
Avg between rounds
$101.3M/yr
Capital velocity
16.6 yr
On record since
2009
First round
8
Rounds on file
How it compares to the market

Benchmarked against 2138 companies in Healthtech. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 241× above median
This company$1.1B
Sector median$4.5M
Latest round — vs other Growth/Late rounds in sector (real $, this stage) 4.4× above median
This company$834.0M
Sector median$191.0M
Modeled value — vs sector median (estimate, all stages) 654× above median
This company$22.1B
Sector median$33.8M

Raised more than 100% of sector peers (real $). Modeled value above 100% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Growth/Late) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful.

This companyCohort peer
$1.0B$10.0B$100.0B$100.0M$1.0B$10.0BCapital raised (log)Brown & Brown Helping Care, Inc. · Growth/Late Raised $1.7B · modeled $40.4B (est)Roman Health Ventures Inc. · Growth/Late Raised $626.8M · modeled $11.7B (est)WP CityMD Topco LLC · Growth/Late Raised $1.1B · modeled $2.9B (est)Teladoc Health, Inc. (this company) Raised $1.1B · modeled $22.1B (est)Teladoc Health, Inc.
CompanyStageRaised · realValue · estvs peer med.
Brown & Brown Helping Care, Inc.Growth/Late$1.7B$40.4B2.39×
Teladoc Health, Inc. this companyGrowth/Late$1.1B$22.1B1.31×
Roman Health Ventures Inc.Growth/Late$626.8M$11.7B0.69×
WP CityMD Topco LLCGrowth/Late$1.1B$2.9B0.17×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Series A$8.9M2009-11-19$40.4M$200.9M85%
Series A$4.0M2010-12-21$18.2M$90.3M85%
Series B$18.6M2011-08-25$103.3M$461.0M85%
Series B$15.0M2013-08-28$83.3M$371.8M85%
Series C$50.3M2014-09-09$335.0M$1.3B85%
Series C$80.0M2016-07-01$533.3M$2.0B85%
Series C$65.0M2017-07-14$433.3M$1.7B90%
Growth/Late$834.0M2020-07-01$8.3B$22.1B90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Series A$8.9M2009-11-19
    • First recorded raise — entered as Series A.
    • 10 investors on this round.
  2. Series A$4.0M2010-12-21
    • Raised 13 mo later, in step with the ~14 mo sector norm.
    • Round 2.2× smaller than the prior — bridge or down round.
    • Revenue band moved $1M–$5M → $5M–$25M.
    • Switched to Rule 505 (was Rule 06).
    • 2 investors on this round.
  3. Series B$18.6M2011-08-25
    • Came back fast: 8 mo vs the ~14 mo sector norm.
    • Round 4.7× larger than the prior — scaling up.
    • Revenue band moved $5M–$25M → $1M–$5M.
    • Switched to Rule 06 (was Rule 505).
    • 6 investors on this round.
  4. Series B$15.0M2013-08-28
    • Raised again after 24 mo — slower than the ~14 mo sector norm.
    • Round roughly the size of the prior one.
    • Revenue band moved $1M–$5M → $5M–$25M.
    • 5 investors on this round.
  5. Series C$50.3M2014-09-09
    • Raised 12 mo later, in step with the ~14 mo sector norm.
    • Round 3.4× larger than the prior — scaling up.
    • Revenue band moved $5M–$25M → $25M–$100M.
    • Switched to Rule 506(b) (was Rule 06).
    • 40 investors on this round.
  6. Series C$80.0M2016-07-01
    • Raised again after 22 mo — slower than the ~14 mo sector norm.
    • Round 1.6× larger than the prior — scaling up.
    • 17 investors on this round.
  7. Series C$65.0M2017-07-14
    • Raised 12 mo later, in step with the ~14 mo sector norm.
    • Round roughly the size of the prior one.
    • Revenue band moved $25M–$100M → $100M+.
    • 116 investors on this round.
  8. Growth/Late$834.0M2020-07-01
    • Raised again after 36 mo — slower than the ~14 mo sector norm.
    • Round 12.8× larger than the prior — scaling up.
    • 172 investors on this round.
Intelligence
2022 ~Q1
Modeled next raise · ~18mo cadence
$2.5B
Modeled next size est.range $1.6B$4.0B
12.8×
Last step-up
$101.3M/yr
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
Dana G. Mead, Jr.6 other2014-09
Dana Mead6 other2011-08
John Reardon6 other2009-11
Michael King5 other2016-07
WILLIAM H. FRIST5 other2016-07
Martin Felsenthal4 other2009-11
THOMAS MCKINLEY4 other2009-11
James Outland3 other2009-11
Kevin Williamson3 other2009-11
Richard Boxer3 other2009-11
Arneek Multani2 other2009-11
Bill Giles2 other2009-11
Thomas G. McKinley2 other2016-07
Bruce Begia1 other2009-11
David B. Snow1 other2020-07
Henry Dreifus1 other2009-11
Jeff Nadler1 other2011-08
Mark D Smith1 other2020-07
MARK HIRSCHHORN1 other2013-08
Martin R. Felsenthal1 other2016-07
Michael M Goldstein1 other2020-07
Mike King1 other2010-12
Samuel Havens1 other2009-11
ADAM C. VANDERVOORT2016-07
Registry & provenance

Teladoc Health, Inc. is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1477449
SEC CIK
Recent activity

Discovered from teladochealth — the partnerships, launches, hiring and press it publishes about itself. Evidence the company is alive and what it is doing now, not financial data.

Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
TelaDoc, IncHospitals and PhysiciansSeed$1.3M$30.0Mnetwork9 shared operators
WP CityMD Topco LLCHealthtechGrowth/Late$1.1B$2.9Bsame sector · same stage
Asc Dental Ventures LlcHealthtechGrowth/Late$1.1B$4.8Bsame sector · same stage
Surround Care, LLCHealthtechGrowth/Late$743.5M$2.0Bsame sector · same stage
Columbia Care Inc.HealthtechGrowth/Late$1.6B$317.0Msame sector · same stage
Brown & Brown Helping Care, Inc.HealthtechGrowth/Late$1.7B$40.4Bsame sector · same stage
Roman Health Ventures Inc.HealthtechGrowth/Late$626.8M$11.7Bsame sector · same stage
Stark Medical Resorts IncHealthtechGrowth/Late$625.0M$4.7Bsame sector · same stage
Semantically similar

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

CompanySectorStageValue · estMatch
Telebelly Health, Inc.HealthtechPre-Seed$13.8M78%
TelehealthOne, LLCOther Health CarePre-Seed$2.6M78%
Encounter Telehealth, LLCHealthtechPre-Seed$14.1M77%
Virtual Health Partners, Inc.HealthtechSeed$43.2M77%
United Telehealth Corp.HealthtechPre-Seed$21.7M77%
Plant Based TeleHealth, Inc.HealthtechPre-Seed$12.2M77%
Telemed2U, Inc.Other Health CareSeries A$127.2M77%
DailyDoctor
Daily telehealth care for people with COPD, CHF, hypertension, and…
Healthtech76%
Frequently asked
How much funding has Teladoc Health, Inc. raised?
Teladoc Health, Inc. has raised approximately $1.1B in disclosed capital across 8 recorded financing rounds, aggregated from public filings.
What is Teladoc Health, Inc.'s estimated valuation?
Provath's modeled valuation for Teladoc Health, Inc. is approximately $22.1B (modeled range $6.1B–$39.8B). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is Teladoc Health, Inc. at?
Teladoc Health, Inc.'s latest modeled financing stage is Growth/Late. Its most recent recorded round closed around Wed Jul 01.
What does Teladoc Health, Inc. do and where is it based?
Teladoc Health, Inc. operates in the Healthtech sector, based in PURCHASE. Get 24/7 access to doctors, mental health support and specialty care with virtual healthcare and telehealth solutions for individuals and organizations from Teladoc Health.
Explore related

See where Teladoc Health, Inc. sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at Teladoc Health, Inc., claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.